Angiodynamics ANGO
NASDAQ ANGO
$12.42 +0.35 (+2.90%)
At close: Nov 11, 2026 · 4:00 PM EST

Angiodynamics (ANGO) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Angiodynamics' Return on Capital Employed [ROCE] came in at -18.77% for fiscal Q1 2027 (quarter ended Aug 31, 2026), down 0.44 percentage points from -18.33% a year earlier but up 2.33 percentage points from the prior quarter.

Analysis

Angiodynamics (ANGO) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2026 (ended May 31, 2026), Angiodynamics' Return on Capital Employed [ROCE] was -20.07%, down 2.13 percentage points from FY2025.

  • Return on Capital Employed [ROCE] carries a five-year change of -13.29 percentage points (FY2021 to FY2026).
  • Going back by fiscal year, Return on Capital Employed [ROCE] was -17.94% in FY2025 (+39.68 pp), -57.62% in FY2024 (-46.46 pp), -11.15% in FY2023 (-5.26 pp) and -5.90% in FY2022 (+0.88 pp).
  • The five-year range for quarterly Return on Capital Employed [ROCE] is -116.92% (fiscal Q2 2025) to -0.63% (fiscal Q1 2024).
  • Year-over-year, Return on Capital Employed [ROCE] increased in five of the last eight quarters, with an average year-over-year change of +22.15 percentage points.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in fiscal Q2 2026 (a gain of 100.29 percentage points), and the weakest in fiscal Q2 2025 (a drop of 115.04 percentage points).
  • Business Quant data shows ANGO's Return on Capital Employed [ROCE] at -21.10% (Q4 2026), -17.84% (Q3 2026) and -16.63% (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 8.51%
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 7.18%
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 6.23%
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 18.68%
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 13.86%
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn 13.22%
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 9.99%
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 11.59%
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 4.76%
10 Angiodynamics 20.48 Mn -146.80 Mn 48.04 Mn -18.77%
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 -18.77%
May 31, 2026 -21.10%
Feb 28, 2026 -17.84%
Nov 30, 2025 -16.63%
Aug 31, 2025 -18.33%
May 31, 2025 -19.34%
Feb 28, 2025 -23.09%
Nov 30, 2024 -116.92%
Aug 31, 2024 -105.07%
May 31, 2024 -83.63%
Feb 29, 2024 -60.92%
Nov 30, 2023 -1.88%
Aug 31, 2023 -0.63%
May 31, 2023 -11.28%
Feb 28, 2023 -7.64%
Nov 30, 2022 -6.84%
Aug 31, 2022 -6.89%
May 31, 2022 -6.01%
Feb 28, 2022 -8.74%
Nov 30, 2021 -8.41%
API Access

Angiodynamics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ANGO&period=max&api_key=YOUR_API_KEY